ミツバチの病原体におけるバクテリオファージ耐性の進化
Emma K Spencer1, Yva Eline2, Lauren Saucedo1
1Department of Biological Sciences, University of Idaho, Moscow, ID, USA.
Microbiology (Reading, England)
|August 20, 2025
まとめ
バクテリオファージ療法では,パエニバシルス幼虫に感染したミツバチの幼虫の治療が有望である. 耐性菌は発生しますが 細菌の成長と毒性を阻害することが多く バクテリオファージが有効な治療法であることを示唆しています
科学分野:
- 微生物学
- ミツバチ飼育
- バクテリオファージの研究
背景:
- ミツバチの幼虫は,コロニーを大きく傷つける病原体であるペニバチルスに脆弱です.
- 現在の抗生物質治療は 規制上の障害や 世界的な制限に直面し 抗生物質耐性を高めています
- バクテリオファージ治療は,蜂のコロニーのペニバシルス幼虫の感染を制御する有望な代替手段です.
研究 の 目的:
- バクテリオファージに対するパエニバシルス幼虫の耐性の進化を調査する.
- バクテリオファージの抵抗が 細菌の毒性や増殖に与える影響を評価する.
- ミツバチの病気の持続的な治療法としてバクテリオファージの可能性を評価する.
主な方法:
- 耐性菌株を選択するために,様々な細菌菌の存在下でパエニバシルス幼虫の培養.
- 根底にある変異を特定するために,細菌菌に耐性のある単離物のゲノム分析.
- ミツバチの幼虫の耐性菌株の毒性を評価する
- 細菌の耐性を克服できる 細菌菌の二次変異を調査する
主要な成果:
- バクテリオファージの耐性は,ペニバシルス幼虫の培養で急速に進化した.
- 耐性変異は,表面受容体,細胞機能,溶解性に関連する遺伝子で発見されました.
- 抵抗性の高い単離体は,蜂の幼虫の成長率が低下し,毒性が著しく低下した.
- バクテリオファージは 細菌の耐性に対抗するために 進化する可能性があるという証拠があります
結論:
- パエニバシルス幼虫の細菌耐性には,病原性の低下などの健康コストが伴う可能性が高い.
- 細菌菌が二次変異を 進化させる可能性は 細菌の耐性を克服するメカニズムを提供します
- バクテリオファージ治療は,蜜蜂コロニーのパエニバシルス幼虫の管理に有効で潜在的に自己限定的な戦略を示しています.
関連する概念動画
Defense Against Bacterial Pathogens
1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Viral Replication: Lysogenic Cycle
230
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
230
Lytic Cycle of Bacteriophages
71.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.9K
DNA Bacteriophages
143
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
143
Lysogenic Cycle of Bacteriophages
63.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.2K
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197


